154 related articles for article (PubMed ID: 21370032)
1. Signaling events initiated by kappa opioid receptor activation: quantification and immunocolocalization using phospho-selective KOR, p38 MAPK, and K(IR) 3.1 antibodies.
Lemos JC; Roth CA; Chavkin C
Methods Mol Biol; 2011; 717():197-219. PubMed ID: 21370032
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of Kir3 following kappa-opioid receptor activation of p38 MAPK causes heterologous desensitization.
Clayton CC; Xu M; Chavkin C
J Biol Chem; 2009 Nov; 284(46):31872-81. PubMed ID: 19773548
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
Bruchas MR; Macey TA; Lowe JD; Chavkin C
J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
[TBL] [Abstract][Full Text] [Related]
4. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
[TBL] [Abstract][Full Text] [Related]
7. Ligand directed signaling differences between rodent and human κ-opioid receptors.
Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
9. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
Bruchas MR; Xu M; Chavkin C
Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
[TBL] [Abstract][Full Text] [Related]
10. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
11. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Bruchas MR; Chavkin C
Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.
McLaughlin JP; Xu M; Mackie K; Chavkin C
J Biol Chem; 2003 Sep; 278(36):34631-40. PubMed ID: 12815037
[TBL] [Abstract][Full Text] [Related]
13. Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase.
Xu M; Bruchas MR; Ippolito DL; Gendron L; Chavkin C
J Neurosci; 2007 Mar; 27(10):2570-81. PubMed ID: 17344394
[TBL] [Abstract][Full Text] [Related]
14. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
Robinson JD; McDonald PH
Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
[TBL] [Abstract][Full Text] [Related]
15. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
[TBL] [Abstract][Full Text] [Related]
16. Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism.
Lemos JC; Roth CA; Messinger DI; Gill HK; Phillips PE; Chavkin C
J Neurosci; 2012 Sep; 32(36):12325-36. PubMed ID: 22956823
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
[TBL] [Abstract][Full Text] [Related]
18. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
McLaughlin JP; Myers LC; Zarek PE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Chavkin C
J Biol Chem; 2004 Jan; 279(3):1810-8. PubMed ID: 14597630
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel functionally selective κ-opioid receptor scaffolds.
White KL; Scopton AP; Rives ML; Bikbulatov RV; Polepally PR; Brown PJ; Kenakin T; Javitch JA; Zjawiony JK; Roth BL
Mol Pharmacol; 2014 Jan; 85(1):83-90. PubMed ID: 24113749
[TBL] [Abstract][Full Text] [Related]
20. Arrestin-mediated activation of p38 MAPK: molecular mechanisms and behavioral consequences.
Chavkin C; Schattauer SS; Levin JR
Handb Exp Pharmacol; 2014; 219():281-92. PubMed ID: 24292835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
